Consistently, we observed a significant elevation in embryonic stem cell-like signatures69 (including the OCT4, SOX2, and NANOG targets) and the canonical HCC stem-cell marker PROM170 in FR‒ HCCs (Supplementary Fig. S6j-m). The gene discussed is SOX2; the disease is hepatocellular carcinoma.